Clinical Trials

NCT04458935 | COMPLETED

25 participants

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2020-07-02

Completion:

2026-06-02

Conditions

• Retinal Hemangioblastoma
• Von Hippel-Lindau Disease

No Results Yet

NCT04417673 | COMPLETED

186 participants

Living With Sickle Cell Disease in the COVID-19 Pandemic

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2020-06-15

Completion:

2022-05-18

Conditions

• Isolation
• Anxiety
• Health Care Utilization
• Sickle Cell Disease
• Pain

No Results Yet

NCT04349657 | ACTIVE_NOT_RECRUITING | NA

286 participants

A Study Evaluating the Endovascular Treatment of Subjects With Stenotic or Restenotic Lesions of the Common Femoral Artery With the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2020-05-05

Completion:

2027-05-31

Conditions

• Peripheral Arterial Disease

Interventions

• DEVICE
• PROCEDURE

No Results Yet

NCT04334525 | COMPLETED | NA

554 participants

Promoting Healthier Eating Among Children in Restaurants

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-11-13

Completion:

2024-11-22

Conditions

• Diet, Healthy

Interventions

• BEHAVIORAL

Results Available

NCT04332367 | RECRUITING | PHASE2

59 participants

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2020-08-01

Completion:

2026-09-30

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT04309760 | WITHDRAWN | NA

0 participants

Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2021-02-28

Completion:

2021-06-15

Conditions

• Gender Dysphoria

Interventions

• OTHER

No Results Yet

NCT04243720 | RECRUITING

100 participants

Immune Resistance Interrogation Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2020-08-26

Completion:

2027-06-30

Conditions

• Cancer
• Solid Tumor
• Metastatic Cancer
• Immune Resistance

No Results Yet

NCT04183699 | TERMINATED | NA

126 participants

Optimizing the Number of Systematic COres During a MRI Target Biopsy

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-06-06

Completion:

2026-06-03

Conditions

• Suspicion of Prostate Cancer With a Positive Multiparametric Magnetic Resonance of the Prostate

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT04167969 | RECRUITING | PHASE1

16 participants

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2021-02-17

Completion:

2027-11-30

Conditions

• Prostate Cancer

Interventions

• OTHER
• PROCEDURE
• DRUG
• DIAGNOSTIC_TEST

No Results Yet

NCT04077047 | COMPLETED | NA

60 participants

Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2022-09-01

Completion:

2025-07-17

Conditions

• HIV/AIDS

Interventions

• BEHAVIORAL

No Results Yet

NCT04070950 | COMPLETED

40 participants

Sexuality of Women With Pelvic Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2009-09-01

Completion:

2010-05-20

Conditions

• Sexual Behavior
• Pelvic Cancer

Interventions

• OTHER

No Results Yet

NCT04067869 | COMPLETED | PHASE3

392 participants

Cytomegalovirus Infection in Patients With HIV-1 Infection

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2010-02-16

Completion:

2010-12-13

Conditions

• Cytomegalovirus Infections
• HIV-1-infection

Interventions

• PROCEDURE

No Results Yet

NCT04055571 | RECRUITING

500 participants

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2019-03-05

Completion:

2027-01-30

Conditions

• Benign or Malignant Pancreatic Diseases

No Results Yet

NCT04054609 | RECRUITING | NA

40 participants

FAZA PET/MRI in CLI Patients Pre and Post Revascularization

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-08-31

Completion:

2027-12-31

Conditions

• Critical Limb Ischemia

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT04032626 | COMPLETED | PHASE2

15 participants

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2020-07-22

Completion:

2025-05-31

Conditions

• Cognitive Impairment, Mild
• Cognitive Dysfunction
• Amyloid Plaque
• Neurodegeneration
• Inflammation, Brain

Interventions

• DRUG

No Results Yet

NCT03998852 | RECRUITING | PHASE3

30 participants

In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2021-04-13

Completion:

2027-04-13

Conditions

• Apathy

Interventions

• DRUG
• DEVICE
• OTHER

No Results Yet

NCT03981575 | RECRUITING

700 participants

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2019-01-01

Completion:

2026-10-01

Conditions

• Myotonic Dystrophy 1
• DM1

No Results Yet

NCT03971253 | COMPLETED

3000 participants

Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-10

Start Date:

2019-09-02

Completion:

2026-05-29

Conditions

• Rheumatoid Arthritis (RA)

Interventions

• DRUG

No Results Yet

NCT03896334 | COMPLETED | NA

139 participants

Effect of Isometric Handgrip Training on Ambulatory Blood Pressure in Patients With Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-04-05

Completion:

2024-07-15

Conditions

• Hypertension

Interventions

• BEHAVIORAL

No Results Yet

NCT03884257 | ACTIVE_NOT_RECRUITING | NA

302 participants

A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2020-02-18

Completion:

2022-09-03

Conditions

• Peripheral Arterial Disease

Interventions

• DEVICE

No Results Yet

NCT03770572 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

7 participants

Gene Therapy for Children With CLN3 Batten Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-11-13

Completion:

2029-09-30

Conditions

• CLN3
• Batten Disease

Interventions

• GENETIC

No Results Yet

NCT03719430 | COMPLETED | PHASE2

27 participants

APX005M and Doxorubicin in Advanced Sarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-03-20

Completion:

2025-12-11

Conditions

• Soft Tissue Sarcoma

Interventions

• DRUG

No Results Yet

NCT03713515 | COMPLETED | PHASE4

652 participants

Bridging the Evidence-to-practice Gap

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2020-12-01

Completion:

2024-05-30

Conditions

• Hypertension

Interventions

• BEHAVIORAL

Results Available

NCT03688334 | COMPLETED | NA

15 participants

Acute Effects of Oxygen Supplementation Among IPF Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-06-01

Completion:

2019-06-01

Conditions

• Idiopathic Pulmonary Fibrosis

Interventions

• DRUG

No Results Yet

NCT03557359 | COMPLETED | PHASE2

35 participants

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-06-12

Completion:

2022-09-20

Conditions

• Gliomas

Interventions

• DRUG

Results Available

NCT03505554 | COMPLETED | PHASE2

9 participants

A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-09-28

Completion:

2025-12-31

Conditions

• Anaplastic Large Cell Lymphoma, ALK-Positive

Interventions

• DRUG

No Results Yet

NCT03495297 | COMPLETED | NA

965 participants

A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-05-07

Completion:

2025-04-01

Conditions

• Ventricular Arrythmia

Interventions

• PROCEDURE

No Results Yet

NCT03447366 | COMPLETED | NA

87 participants

Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-01-30

Completion:

2022-04-30

Conditions

• Respiration, Artificial
• Vascular Filling
• Echocardiography

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03348670 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3

600 participants

Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2023-08-18

Completion:

2026-11-18

Conditions

• Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT03311152 | COMPLETED | NA

639 participants

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-02-12

Completion:

2024-10-17

Conditions

• Hepatocellular Carcinoma
• Cirrhosis

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03305341 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

20 participants

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2025-05-18

Completion:

2026-11-18

Conditions

• Covid19

Interventions

• BIOLOGICAL

No Results Yet

NCT03295383 | ACTIVE_NOT_RECRUITING | PHASE3

92 participants

Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2019-07-11

Completion:

2027-03-31

Conditions

• Severe Forms of Mucous Membrane Pemphigoid

Interventions

• DRUG

No Results Yet

NCT03294863 | TERMINATED | NA

49 participants

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2017-03-15

Completion:

2021-12-01

Conditions

• Linear Cutaneous Wound

Interventions

• DEVICE
• OTHER

Results Available

NCT03247088 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

74 participants

Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2017-07-30

Completion:

2027-12-31

Conditions

• Recurrent Acute Myeloid Leukemia
• Refractory Acute Myeloid Leukemia

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT03224767 | ACTIVE_NOT_RECRUITING | PHASE2

24 participants

Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2018-01-05

Completion:

2023-09-22

Conditions

• BRAF V600E Mutation Present
• Papillary Craniopharyngioma

Interventions

• DRUG
• OTHER

Results Available

NCT03202316 | ACTIVE_NOT_RECRUITING | PHASE2

37 participants

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2017-08-11

Completion:

2027-12-31

Conditions

• Recurrent Breast Inflammatory Carcinoma
• Stage IV Breast Inflammatory Carcinoma

Interventions

• DRUG
• OTHER

No Results Yet

NCT03017820 | RECRUITING | PHASE1

99 participants

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2017-04-04

Completion:

2028-12-31

Conditions

• B-Cell Non-Hodgkin Lymphoma
• Histiocytic and Dendritic Cell Neoplasm
• Myelodysplastic Syndrome
• Previously Treated Myelodysplastic Syndrome
• Recurrent Adult Acute Myeloid Leukemia
• Recurrent Anaplastic Large Cell Lymphoma
• Recurrent Angioimmunoblastic T-Cell Lymphoma
• Recurrent Mycosis Fungoides
• Recurrent Plasma Cell Myeloma
• Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
• Recurrent T-Cell Non-Hodgkin Lymphoma
• Refractory Acute Myeloid Leukemia
• Refractory Anaplastic Large Cell Lymphoma
• Refractory Angioimmunoblastic T-Cell Lymphoma
• Refractory Mycosis Fungoides
• Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
• Refractory Plasma Cell Myeloma
• Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
• Refractory T-Cell Non-Hodgkin Lymphoma

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT03016377 | ACTIVE_NOT_RECRUITING | PHASE1

15 participants

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2012-03-22

Completion:

2025-09-12

Conditions

• Acute Lymphoblastic Leukemia
• Immune System Diseases
• Immunoproliferative Disorders

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT02953717 | COMPLETED | NA

81 participants

Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2016-02-29

Completion:

2023-01-11

Conditions

• Neoplasm Metastasis

Interventions

• RADIATION

No Results Yet

NCT02917083 | RECRUITING | PHASE1

60 participants

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-10

Start Date:

2017-05-08

Completion:

2027-04-30

Conditions

• Hodgkin's Lymphoma
• Non-Hodgkin Lymphoma

Interventions

• GENETIC

No Results Yet